STRATA Skin Ownership
| SSKN Stock | USD 2.94 0.11 3.61% |
Shares in Circulation | First Issued 2004-09-30 | Previous Quarter 3.5 M | Current Value 4 M | Avarage Shares Outstanding 10.1 M | Quarterly Volatility 14.5 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
STRATA |
STRATA Stock Ownership Analysis
About 60.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.31. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. STRATA Skin Sciences recorded a loss per share of 2.6. The entity last dividend was issued on the 7th of April 2017. The firm had 1:10 split on the 7th of June 2024. STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania. Strata Skin operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 115 people. To find out more about STRATA Skin Sciences contact Dolev Rafaeli at 215 619 3200 or learn more at https://www.strataskinsciences.com.Besides selling stocks to institutional investors, STRATA Skin also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different STRATA Skin's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align STRATA Skin's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
STRATA Skin Quarterly Liabilities And Stockholders Equity |
|
STRATA Skin Insider Trades History
Roughly 3.0% of STRATA Skin Sciences are currently held by insiders. Unlike STRATA Skin's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against STRATA Skin's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of STRATA Skin's insider trades
STRATA Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as STRATA Skin is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading STRATA Skin Sciences backward and forwards among themselves. STRATA Skin's institutional investor refers to the entity that pools money to purchase STRATA Skin's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Jpmorgan Chase & Co | 2024-06-30 | 105 | Financial Perspectives Inc | 2024-09-30 | 101 | Royal Bank Of Canada | 2024-06-30 | 39.0 | Bank Of America Corp | 2024-06-30 | 17.0 | Hanson Mcclain Inc | 2024-09-30 | 5.0 | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 2.0 | Pnc Financial Services Group Inc | 2024-09-30 | 2.0 | Goldman Sachs Group Inc | 2024-06-30 | 0.0 | State Street Corp | 2024-06-30 | 0.0 | 22nw, Lp | 2024-06-30 | 537 K | Nantahala Capital Management, Llc | 2024-09-30 | 403.9 K |
STRATA Skin Sciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific STRATA Skin insiders, such as employees or executives, is commonly permitted as long as it does not rely on STRATA Skin's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases STRATA Skin insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
STRATA Skin Outstanding Bonds
STRATA Skin issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. STRATA Skin Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most STRATA bonds can be classified according to their maturity, which is the date when STRATA Skin Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
STRATA Skin Corporate Filings
| 22nd of November 2024 Other Reports | ViewVerify | |
10Q | 14th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 13th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 29th of October 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Pair Trading with STRATA Skin
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if STRATA Skin position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in STRATA Skin will appreciate offsetting losses from the drop in the long position's value.Moving against STRATA Stock
| 0.65 | CVS | CVS Health Corp Aggressive Push | PairCorr |
| 0.35 | PHG | Koninklijke Philips | PairCorr |
| 0.33 | FIGS | Figs Inc | PairCorr |
The ability to find closely correlated positions to STRATA Skin could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace STRATA Skin when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back STRATA Skin - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling STRATA Skin Sciences to buy it.
The correlation of STRATA Skin is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as STRATA Skin moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if STRATA Skin Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for STRATA Skin can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.60) | Revenue Per Share 9.347 | Quarterly Revenue Growth 0.022 | Return On Assets (0.07) | Return On Equity (0.63) |
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.